AdventHealth Celebration

Freight Farms Drives Growth of Container Farm Adoption Across Nonprofit, Healthcare and Education Sectors

Retrieved on: 
Wednesday, January 31, 2024

BOSTON, Jan. 31, 2024 /PRNewswire/ -- Freight Farms, Inc. ("Freight Farms"), an innovative agtech company and leader in hydroponic container farming, and Agrinam Acquisition Corporation (TSX:AGRI.U) ("Agrinam") announced substantial growth in year-over-year orders of Freight Farms' flagship Greenery farm in 2023 (32%), showcasing need from institutions and communities for localized, sustainable food. To meet this demand, Freight Farms saw customers scaling the number of farm units in their operations increase by approximately 70%, driven primarily by growth of 147% in non-profit and healthcare customers and 27% in education customers.

Key Points: 
  • BOSTON, Jan. 31, 2024 /PRNewswire/ -- Freight Farms, Inc. ("Freight Farms"), an innovative agtech company and leader in hydroponic container farming, and Agrinam Acquisition Corporation (TSX:AGRI.U) ("Agrinam") announced substantial growth in year-over-year orders of Freight Farms' flagship Greenery farm in 2023 (32%), showcasing need from institutions and communities for localized, sustainable food.
  • To meet this demand, Freight Farms saw customers scaling the number of farm units in their operations increase by approximately 70%, driven primarily by growth of 147% in non-profit and healthcare customers and 27% in education customers.
  • This continued momentum sets the stage for the newest iteration of Freight Farms' container farm, the Garden.
  • Some organizations to highlight include:
    Puerto Rico's Farm in the City has leveraged Freight Farms' products to supply its communities with high quality, locally-grown fresh produce for over the last five years.

World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System

Retrieved on: 
Tuesday, January 9, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240109791302/en/
    Example of HistoSonics technology targeting kidney tissue to be destroyed in a non-invasive histotripsy procedure.
  • While surgical intervention is the “gold standard” in removing kidney tumors, a non-invasive approach with histotripsy provides the potential to destroy targeted tumors without damaging non-targeted kidney tissue.
  • Use of the Edison System in kidney applications is limited by federal law to investigational use.
  • The #HOPE4KIDNEY Trial is expected to support a future expansion of the indication to include the destruction of kidney tissue/tumors.

United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM

Retrieved on: 
Thursday, September 21, 2023

VIENNA, Sept. 21, 2023 /PRNewswire/ -- United Imaging Healthcare, a global leader in advanced medical imaging and radiotherapy equipment, introduces its next-generation PET/CT systems, the uMI Panorama™, and the integrated molecular technology platform named uExcel, at the European Association of Nuclear Medicine (EANM) 2023 annual meeting taking place from September 9-12 in Vienna, Austria. As the sponsor of the "EANM Young Authors' Award" and "EANM Technologist Award" this year, United Imaging is playing a significant role in driving innovation in the field of molecular imaging and nuclear medicine on a global scale.

Key Points: 
  • The new wide-bore uMI Panorama is a family of products that includes the uMI Panorama, the uMI Panorama GS, and the NeuroEXPLORER.
  • The uMI Panorama GS, deriving its name from the term "Gold Standard", was born to set the gold standard in molecular imaging and revolutionize whole-body PET imaging.
  • In tandem with uMI Panorama, the uExcel, is an advanced molecular imaging technology platform meticulously integrated with both hardware and software components.
  • (Note: The uMI Panorama and the uMI Panorama GS are CE pending, not commercially available yet.

Southern Glazer’s Wine & Spirits Promotes Lee Brian Schrager to Chief Communications Officer

Retrieved on: 
Wednesday, January 11, 2023

Southern Glazer's Wine & Spirits (Southern Glazer's)—the world’s preeminent distributor of beverage alcohol—today announced that Lee Brian Schrager has been promoted to the position of Chief Communications Officer, continuing to report to Chief Executive Officer Wayne E. Chaplin.

Key Points: 
  • Southern Glazer's Wine & Spirits (Southern Glazer's)—the world’s preeminent distributor of beverage alcohol—today announced that Lee Brian Schrager has been promoted to the position of Chief Communications Officer, continuing to report to Chief Executive Officer Wayne E. Chaplin.
  • In his newly created role, Mr. Schrager will continue to oversee the Company’s corporate communications functions, including public relations, employee communications, the Company’s corporate website, as well as its Intranet-based communications.
  • In his most recent position of Senior Vice President, Communications & Corporate Social Responsibility, which he has held since 2016, Mr. Schrager has helped significantly strengthen and expand the Company’s communications capabilities.
  • In 2011, Mr. Schrager commemorated the 10th anniversary of SOBEWFF® with the release of his first book, Food Network South Beach Wine & Food Festival Cookbook.

Elevating Women's Healthcare Through Advances in Robotics Surgery

Retrieved on: 
Thursday, October 13, 2022

CELEBRATION, Fla., Oct. 13, 2022 /PRNewswire/ -- Surgical robots have assisted surgery for several decades. Still, significant advances in technology in recent years have completely transformed the way surgeons perform surgery and how patients recover. At Celebration Obstetrics & Gynecology, the Director of Minimally Invasive Surgery, Dr. John C. Kim, is leading the way for minimally invasive surgery in women's healthcare.

Key Points: 
  • Still, significant advances in technology in recent years have completely transformed the way surgeons perform surgery and how patients recover.
  • At Celebration Obstetrics & Gynecology, the Director of Minimally Invasive Surgery, Dr. John C.Kim,isleadingthewayfor minimally invasive surgery in women's healthcare.
  • John C. Kim, MD, FACOG, is a board-certified OB-GYN physician with advanced fellowship training in endoscopic women's pelvic surgery and robotic minimally invasive surgery.
  • Following residency, he completed fellowships in minimally invasive robotic surgery and endoscopic women's pelvic surgery at Florida Hospital Celebration Health.

KB Home Announces the Grand Opening of Bellaviva at Westside, a New-Home Community in Kissimmee, Florida

Retrieved on: 
Wednesday, August 3, 2022

KB Home (NYSE: KBH) today announced the grand opening of Bellaviva at Westside, a new, single-family home community in the Champions Gate area in Kissimmee.

Key Points: 
  • KB Home (NYSE: KBH) today announced the grand opening of Bellaviva at Westside, a new, single-family home community in the Champions Gate area in Kissimmee.
  • View the full release here: https://www.businesswire.com/news/home/20220803005378/en/
    KB Home announces the grand opening of Bellaviva at Westside, a new-home community in Kissimmee, Florida.
  • Bellaviva at Westsides location is convenient to major highways for a short commute to area employers and Walt Disney World Resort.
  • Residents will enjoy the community amenities, including a pool and playground, said Fred Wyborski, President of KB Homes Orlando division.

Memic Announces Multiple Upcoming Presentations of Hominis® Surgical System at Society of Robotic and Digital Surgery 2022 Annual Meeting

Retrieved on: 
Thursday, June 23, 2022

ET

Key Points: 
  • ET
    TEL AVIV, Israel and FORT LAUDERDALE, Fla., June 23, 2022 /PRNewswire/ -- Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that multiple abstracts detailing clinical data related to the Hominis Surgical System for robotic-assisted transvaginal hysterectomy were accepted for presentation at the Society of Robotic and Digital Surgery (SRS) 2022 Annual Meeting, taking place June 30-July 3 at the Disney Yacht & Beach Club Resort in Florida.
  • Conditt and Lightcap and Mr. Yaghini and Mr. McKittrick
    Memic, who is sponsoring the meeting, will hold an industry product theatre titled "A Novel Approach to Robotics Assisted Vaginal Surgery" on Saturday, July 2 from 12:00-1:00 p.m.
  • In addition, the company plans to host a special on-site event called "Project M" for employees and surgeons on Friday, July 1 at 6:00 p.m.
  • Memic, founded in 2013 and based in Tel Aviv, Israel with a wholly owned subsidiary based in Fort Lauderdale, Florida, is a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology.

Memic Innovative Surgery Named to Fast Company's Annual List of World's 50 Most Innovative Companies for 2022

Retrieved on: 
Tuesday, March 8, 2022

TEL AVIV, Israel andFORT LAUDERDALE, Fla., March 8, 2022 /PRNewswire/ --Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announcedthe company has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2022.

Key Points: 
  • TEL AVIV, Israel andFORT LAUDERDALE, Fla., March 8, 2022 /PRNewswire/ --Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announcedthe company has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2022.
  • In addition to the World's 50 Most Innovative Companies, 528 organizations are recognized across 52 categories.
  • "We are honored to be part of Fast Company's list of World's 50 Most Innovative Companies for 2022," said Dvir Cohen, co-founder and chief executive officer of Memic.
  • "Our priority at Memic is to transform surgery and patient lives with our proprietary Hominis Surgical System, first starting with women's healthcare and use in gynecologic surgery.

KB Home Announces the Grand Opening of Mirabella, a New-Home Community in Davenport, Florida

Retrieved on: 
Tuesday, August 10, 2021

KB Home (NYSE: KBH) today announced the grand opening of Mirabella, a new home community in Davenport that offers single-family homes and townhomes.

Key Points: 
  • KB Home (NYSE: KBH) today announced the grand opening of Mirabella, a new home community in Davenport that offers single-family homes and townhomes.
  • View the full release here: https://www.businesswire.com/news/home/20210810005215/en/
    KB Home announces the grand opening of Mirabella, a new-home community in Davenport, Florida.
  • (Photo: Business Wire)
    The homes at Mirabella showcase popular design characteristics like gourmet kitchens overlooking expansive great rooms and master suites with walk-in closets.
  • The homes also feature the KB Home Office, a dedicated room that homebuyers can personalize for the way they work.

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

Retrieved on: 
Tuesday, May 25, 2021

Initially, AdventHealth and Sema4 will focus on accelerating research in AdventHealths Orlando-area network, which includes more than 20 hospitals and emergency departments, and accounts for more than two million patient visits annually.

Key Points: 
  • Initially, AdventHealth and Sema4 will focus on accelerating research in AdventHealths Orlando-area network, which includes more than 20 hospitals and emergency departments, and accounts for more than two million patient visits annually.
  • Nationally, the company has 50 hospitals and hundreds of care sites across almost a dozen states.
  • AdventHealth views genomics and personalized medicine as critical to the future of wellness and health care, and we are delighted to collaborate with Sema4 on this important journey, said Dr. Steven R. Smith , chief scientific officer for AdventHealth.
  • At the center of this precision medicine collaboration, AdventHealth and Sema4 will conduct data structuring and curation of the combined genomic and clinical data, which, along with Sema4 investigative tools, will allow clinicians and scientists to advance research and discovery.